Treatment of pediatric heterozygous familial hypercholesterolemia 7 years after the EAS recommendations: Real-world results from a large French cohort

CONCLUSION: Pediatric patients with FH followed up in specialist lipid clinics in France receive late treatment, undertreatment, or suboptimal treatment and half of them do not reach the therapeutic LDL-C goal. Finding a more efficient framework for linking scientific evidence to clinical practice is needed.PMID:38538465 | DOI:10.1016/j.arcped.2024.01.004

Source: Archives de Pediatrie - March 27, 2024 Category: Pediatrics Authors: Noel Peretti Alexandre Vimont Emmanuel Mas Julie Lemale Rachel Reynaud Patrick Tounian Pierre Poinsot Liora Restier Fran çois Paillard Alain Pradignac Yann Pucheu Jean-Pierre Rab ès Eric Bruckert Antonio Gallo Sophie B éliard Source Type: research